Ireland· IE-PA-PA0788/001/002
ProHance, 279.3 mg/ml, Solution for Injection, 10 ml vial
A gadoteridol product containing gadoteridol, registered in Ireland by Bracco International B.V.. The same ATC class is registered in 14 of our 19 countries.
Checked against HPRA (Ireland) on
Informational only — not a medical device.
Where it is registered
Gadoteridol is registered in 14 of 19 countries.
Countries holding a registration under ATC V08CA04 (gadoteridol), each read from that country’s own register.
- This record: Ireland, from HPRA (Ireland)
- 7 of them publish a price we can compare per daily dose
Gadoteridol · ATC V08CA04
14 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Ireland
- Japan
- Netherlands
- Norwayprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
HPRA (Ireland)- Active substance
- Gadoteridol
- Manufacturer
- Bracco International B.V.
- Country
- Ireland (IE)
- ATC code
- V08CA04
- ATC class
- Gadoteridol
- Reimbursed
- Not published by this register
- Source register
- HPRA (Ireland)
- Last checked
- September 28, 2026
Packs & prices · 1
- ie_pa_numberPA0788/001/002
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
19 interactions on record for gadoteridol.
Graded by severity as the source publishes them — 19 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Gadoteridol · interactions on record
19 records
- 19 moderate
Most severe, free to view
- PindololC07AA03moderate
- PropranololC07AA05moderate
- TimololC07AA06moderate
- SotalolC07AA07moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Gadoteridol in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FinlandProhanceBracco International B.V.
- United StatesProHanceBRACCO DIAGNOSTICS INC
- SwitzerlandProHance 0.5 mmol/ml, soluzione iniettabile (flacone)Bracco Suisse SA
- BelgiumProhance 279.3 mg/mlBracco Imaging Deutschland
- CzechiaPROHANCEBracco Imaging Deutschland GmbH, Konstanz
- United KingdomProHance 0.5mmol/ml solution for injection 10ml pre-filled syringesBracco UK Ltd
- FrancePROHANCE 0,5 mmol/mL, solution injectableBRACCO IMAGING FRANCE
- GermanyProhanceBracco Imaging Deutschland Gmbh
Authorised across Europe · EMA
The same active substance is authorised in 25 EEA countries. Names it is sold under:
- Austria · Prohance
- Belgium · Prohance
- Czechia · Prohance
- Germany · Prohance
- Denmark · Prohance
- Estonia · Prohance
- Spain · Prohance
- Finland · Prohance
- France · Prohance
- United Kingdom (Northern Ireland) · Prohance
- Greece · Prohance
- Croatia · Prohance
- Hungary · Prohance
- Italy · Prohance
- Lithuania · Prohance
- Luxembourg · Prohance
- Latvia · Prohance
- Netherlands · Prohance
- Norway · Prohance
- Poland · Prohance
- Portugal · Prohance
- Romania · Prohance
- Sweden · Prohance
- Slovenia · Prohance
- Slovakia · Prohance
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/66ad46be-5845-4d27-b784-2d26dfc3a7d1 GET /v1/drugs/66ad46be-5845-4d27-b784-2d26dfc3a7d1?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Solution for injection",
"routes": [
"Intravenous use"
],
"source": "hpra",
"atc_all": [
"V08CA",
"V08CA04"
],
"strength": null,
"pa_number": "PA0788/001/002",
"substances": [
"Gadoteridol"
],
"legal_basis": "Full application (Article 8(3) of Directive No 2001/83/EC)",
"market_info": "Marketed",
"authorised_at": "23/02/1993",
"dispensing_status": "Product subject to prescription which may not be renewed (A)",
"registration_status": "AU",
"supply_legal_status": "Supply through pharmacies only",
"interchangeable_code": null
}See everything about gadoteridol.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.